Hello from Lorenci! 👋
As a PhD researcher in the Nanomaterials for Biomedical Applications group, my work confronts a central obstacle in nanomedicine. The clinical translation of promising inorganic nanoparticles is often stalled by a trio of manufacturing challenges: inconsistent results from batch-to-batch synthesis, milligram scale production, and the lack of scalable methods for multi-step processes like surface functionalization and encapsulation. These bottlenecks create a significant gap between initial discovery and viable therapeutic agents for the patients.
My research tries to directly tackle these issues by engineering an integrated, automated platform. I design and build continuous-flow systems that manage the entire nanoparticle lifecycle, from the initial synthesis of the inorganic/magnetic core to its subsequent surface modification and encapsulation. This process is governed by custom software and automated devices, allowing for precise, digital control over every critical parameter of the material's development.
The result is a reproducible and highly scalable platform capable of producing functionally complete, ready-to-use theranostic agents. This innovation fundamentally enhances material quality and consistency. More importantly, it drastically accelerates the R&D cycle by enabling rapid, data-driven optimization, thereby closing the gap between lab-scale concepts and preclinical evaluation.
